Computed Tomography Market Report Scope & Overview:
The Computed Tomography Market was valued at USD 8.02 Billion in 2025 and is projected to reach USD 8.52 Billion in 2026 and USD 14.61 Billion by 2035, registering a CAGR of 6.18% over the forecast period. Growth is anchored in the rising burden of cancer, cardiovascular, and neurological disease, the expansion of screening programs, and the arrival of photon-counting detectors and artificial intelligence reconstruction that improve image quality at lower radiation dose. Hospitals and imaging centers are replacing aging scanners with systems that offer faster scan times, spectral information, and workflow automation.
North America was the highest contributor to the market, making up 35.40% in 2025 due to its installed base, higher volume of procedures, favorable reimbursement for diagnostic imaging, and early adoption of new detector technology. The US dominates in the regional market owing to the replacement of scanners on a routine basis, and growth of outpatient imaging networks. Asia Pacific is the fastest-growing region due to construction of hospitals, higher screening initiatives, and presence of strong domestic scanner manufacturers in countries such as China, Japan, India, and South Korea.

To Get More Information On Computed Tomography Market - Request Free Sample Report
Key Report Takeaways
- By product type, conventional CT scanners held a 40.18% share in 2025, while cone beam CT scanners are the fastest growing.
- By technology, iterative reconstruction CT accounted for 37.92% of the market in 2025, while photon-counting CT is the fastest growing.
- By application, oncology led with a 29.34% share in 2025, while neurology is the fastest growing.
- By end user, hospitals and medical centers represented 62.18% of the market in 2025, while diagnostic imaging centers are the fastest growing.
- By region, North America led with a 35.40% share in 2025, while Asia Pacific is expected to expand fastest at a CAGR of 8.17%.
Market Trends and Insights
Photon-counting detectors are moving from academic centers to wider clinical use. Several manufacturers now offer commercial systems, and hospitals are evaluating them for cardiac, lung, and pediatric imaging where finer detail and lower dose matter most.
Artificial intelligence is changing the full scan workflow. Software now assists with patient positioning, dose optimization, reconstruction, and automatic reporting of findings, which shortens exam times and reduces variation between operators.
Imaging is leaving the radiology suite. Mobile and compact scanners are being developed for emergency vehicles, intensive care units, and field settings, which brings computed tomography closer to patients who cannot be moved easily.
Service and software contracts are growing in importance. Vendors increasingly sell upgrade paths, remote service, and cloud analytics with each scanner, so recurring revenue is rising alongside equipment sales.
Drivers Impact Analysis
|
Driver |
(~) Percentage Point Impact on Market CAGR |
Geographic Relevance |
Impact Timeline |
|---|---|---|---|
|
Rising prevalence of cancer, cardiovascular, and neurological disease |
+2.14% |
Global |
Medium term (2 to 4 years) |
|
Technological advances in photon-counting detectors and AI reconstruction |
+1.86% |
North America, Europe, Asia Pacific |
Short term (2 years or less) |
|
Expansion of screening programs and emergency imaging volumes |
+1.42% |
North America, Asia Pacific |
Medium term (2 to 4 years) |
|
Replacement of aging scanners and hospital infrastructure investment |
+1.18% |
Global |
Short term (2 years or less) |
|
Growth of diagnostic imaging centers in emerging economies |
+0.84% |
Asia Pacific, Latin America, Middle East & Africa |
Long term (4 years or more) |
Rising Prevalence of Cancer, Cardiovascular, and Neurological Disease
Computed tomography is central to the diagnosis, staging, and follow-up of cancer, and it is a first-line test for stroke, trauma, and many cardiovascular conditions. As populations age and chronic disease rates climb, the number of scans ordered per patient also rises. Oncology care in particular requires repeated imaging to monitor treatment response. Hospitals therefore plan for continued growth in volume, and they invest in more scanners and faster systems to avoid long waits for patients with suspected serious illness.
Technological Advances in Photon-Counting Detectors and AI Reconstruction
Photon-counting detectors count individual X-ray photons and measure their energy, which improves spatial resolution, reduces noise, and supports spectral imaging without a separate scan. For instance, in March 2025, Siemens Healthineers received U.S. clearance for its Naeotom Alpha class of photon-counting scanners, and in March 2026 GE HealthCare received clearance for its Photonova Spectra system. Deep learning reconstruction further lowers dose and speeds exams. These advances create a clear upgrade case for hospitals with older equipment and rising service bills.
Expansion of Screening Programs and Emergency Imaging Volumes
Low-dose computed tomography is used for lung cancer screening in high-risk groups in several countries, and coronary imaging is increasingly used to assess chest pain without invasive tests. Emergency departments rely on rapid scans to identify bleeding, clots, and injuries, and imaging orders per visit continue to grow. National screening programs and public health campaigns bring new patients to imaging services. Higher volumes strain existing scanners, which encourages hospitals and imaging centers to add capacity and select faster scanning systems.
Replacement of Aging Scanners and Hospital Infrastructure Investment
Many installed scanners are more than ten years old and lack the dose reduction, speed, and software features of current models. Manufacturers and hospitals prefer to replace them because service costs rise with age and image quality falls short of modern expectations. Capital budgets recovering from earlier constraints are being directed to imaging, and new hospital construction in Asia, the Middle East, and Latin America includes multiple scanners. Trade-in programs and leasing models make replacement cycles easier for buyers with limited funds.
Growth of Diagnostic Imaging Centers in Emerging Economies
Private diagnostic chains are opening in India, Southeast Asia, Latin America, and the Gulf to serve patients who face long waits in public hospitals. These centers buy mid-range and high-end scanners, often with financing from manufacturers. Rising incomes, insurance coverage, and health awareness increase demand for scans. Local manufacturers offer lower-priced systems that suit new entrants, while global companies provide premium models and service networks. The expanding network of centers creates sustained demand for new installations beyond traditional hospital customers.
Restraints Impact Analysis
|
Restraint |
(~) Percentage Point Impact on Market CAGR |
Geographic Relevance |
Impact Timeline |
|---|---|---|---|
|
High capital and maintenance cost of scanners |
-1.34% |
Global |
Short term (2 years or less) |
|
Radiation exposure concerns and dose regulation |
-0.92% |
North America, Europe |
Medium term (2 to 4 years) |
|
Shortage of radiologists and CT technologists |
-0.78% |
Global |
Medium term (2 to 4 years) |
|
Supply chain constraints and trade uncertainty for components |
-0.56% |
North America, Asia Pacific |
Short term (2 years or less) |
High Capital and Maintenance Cost of Scanners
A modern computed tomography system costs several hundred thousand to several million dollars, and installation requires shielding, power, and cooling upgrades. Service contracts, replacement tubes, and software licenses add recurring costs. Smaller hospitals and public facilities in developing regions often defer purchases or buy refurbished systems, which limits new equipment demand. Photon-counting systems carry a particularly high price premium, so many buyers wait for clear evidence of clinical and financial benefit before committing to them, which slows adoption in cost-sensitive markets.
Radiation Exposure Concerns and Dose Regulation
Computed tomography delivers a higher radiation dose than ordinary X-ray, and public and professional attention to cumulative exposure remains strong. Regulators and professional societies recommend dose monitoring, justification of scans, and the use of alternatives such as ultrasound or magnetic resonance imaging where appropriate. Pediatric imaging is especially sensitive. These concerns do not stop clinical use, but they moderate growth in routine screening and push providers toward protocols that limit unnecessary scans and add compliance work for every imaging department.
Shortage of Radiologists and CT Technologists
Imaging volumes are growing faster than the workforce that operates scanners and interprets results. Technologist vacancies force centers to reduce operating hours, and radiologist shortages lengthen reporting times. Even when a hospital can afford a new scanner, staffing limits can reduce the utilization that justifies the purchase. Automation and teleradiology help, yet training new specialists takes years, so workforce constraints will continue to limit the pace at which new capacity translates into additional scans and revenue for operators in every region worldwide.
Supply Chain Constraints and Trade Uncertainty for Components
Scanners depend on specialized components such as X-ray tubes, detectors, and high-voltage parts that come from a small number of suppliers across several countries. Trade restrictions, tariffs, and logistics delays can raise costs and extend delivery times. Manufacturers are diversifying sources and building local assembly, but these adjustments take time. Uncertainty makes hospitals cautious about committing to large orders, and buyers in some markets face price increases that reduce the budget available for other imaging equipment and related software upgrades.
Computed Tomography Market Segment Analysis
By Product Type, Conventional CT Scanners Dominate Computed Tomography Market; Cone Beam CT Scanners to Register Fastest Growth.
Conventional CT scanners held a 40.18% share in 2025 because they remain the standard whole-body imaging system in hospitals and diagnostic centers. They support the widest range of examinations, from emergency trauma and stroke to oncology and cardiac imaging. The installed base is large, and manufacturers offer many slice configurations and price points. Radiology departments value their speed, versatility, and established workflows, and replacement purchases of conventional systems provide a stable foundation of demand for scanner makers worldwide each year.
Cone beam CT scanners are projected to grow at a CAGR of 8.42% between 2026 and 2035, as dental, orthopedic, ear, nose and throat, and interventional users adopt compact systems that deliver three-dimensional images at lower dose and cost. Cone beam systems fit in clinics and operating rooms, and they are often used for guidance during procedures. Lower purchase prices and smaller space needs allow practices outside hospitals to buy them, which widens the customer base for imaging suppliers.

By Technology, Iterative Reconstruction CT Dominates Computed Tomography Market; Photon-Counting CT to Register Fastest Growth.
The sales share of iterative reconstruction CT was 37.92% in 2025 since most of the machines produced within recent years feature either iterative or model-based reconstruction techniques that are used to minimize the effect of noise and reduce the level of radiation exposure. The technique is available for both midrange and high-end scanners, as well as for older systems through a software upgrade. Hospital institutions appreciate the tradeoff offered by the method in terms of image quality, scanning speed, and cost, as well as familiarity of the images among radiologists.
Photon-counting CT is expected to grow at a CAGR of 10.64% during 2026-2035 due to commercial clearances and accumulating clinical evidence of higher resolution, decreased dose, and inherent spectral information. The cardiac, pulmonary, inner ear, and pediatric examinations gain the most from it. At present, major competitors have started to offer competitive systems; therefore, availability will increase, as well as costs will go down eventually. Academic institutions serve as pioneers, while community hospitals will join in during the next couple of years.
By Application, Oncology Dominates Computed Tomography Market; Neurology to Register Fastest Growth.
Oncology held a 29.34% share in 2025 because computed tomography is used throughout cancer care, including detection, staging, treatment planning, radiation therapy simulation, and response monitoring. Patients often receive repeated scans over months or years, which makes oncology the largest source of examination volume. Cancer centers also buy advanced systems for guided biopsies and ablation. Rising cancer incidence and expanding screening programs keep this application at the center of purchasing decisions, particularly at large academic cancer centers and specialty hospitals.
Neurology is expected to record a CAGR of 7.21% from 2026 to 2035 as stroke pathways, trauma care, and dementia evaluation depend on rapid brain imaging. Mobile stroke units and emergency department scanners reduce the time to diagnosis, and perfusion and angiography protocols guide treatment selection. Artificial intelligence tools that flag hemorrhage and large vessel occlusion are being integrated with scanners. An aging population increases the number of patients who need urgent neurological imaging in emergency and outpatient settings.
By End User, Hospitals and Medical Centers Dominate Computed Tomography Market; Diagnostic Imaging Centers to Register Fastest Growth.
The share of hospitals and medical centers in 2025 was 62.18%, as they serve as the primary place of treatment for emergency, inpatients, and oncological patients, requiring rapid diagnostic imaging. Large centers employ multiple devices and tend to have service agreements with manufacturers. Hospitals and medical institutions have budget for purchasing expensive products, while academic institutions are leaders in adoption of innovative technologies. Ownership of the patient relationship and referral process guarantees the stable volume of procedures and replacement of equipment on a continuous basis.
Diagnostic imaging centers are expected to register a CAGR of 7.46% in the period from 2026 to 2035 due to the growing number of outpatient chains in connection with the cost-cutting at hospitals and patients' need in more convenient appointments. Diagnostic imaging centers prioritize efficient workflow and prefer scanners with fast examinations, automated processes, and high reliability. The development of private equity investments and franchising makes the creation of new centers quick, especially in the USA, India, and Gulf region.
Geography Analysis
|
Region |
Major Country |
Share within Region, 2025 (%) |
|---|---|---|
|
North America |
United States |
82.84% |
|
Europe |
Germany |
23.74% |
|
Asia Pacific |
China |
44.62% |
|
Middle East & Africa |
Saudi Arabia |
29.37% |
|
Latin America |
Brazil |
47.26% |
North America Computed Tomography Market
North America was the market leader in 2025 with a share of 35.40%, driven by a large installed base, procedure volumes, positive reimbursement environment, and adoption of technology innovations. The lion's share of demand from the region comes from the United States, with a value of USD 2.35 Billion in 2025 expected to grow at a CAGR of 6.06% until 2035. Replacement of scanners takes place regularly, and the expansion of outpatient imaging networks continues, whereas Canada and Mexico drive steady demand through investments in public hospitals and private imaging facilities.
Launches and clearances of products drive purchases in the region. In March 2026, for instance, GE HealthCare cleared its first photon-counting CT scanner in the United States, Photonova Spectra, with a silicon-based detector that the company introduced to the market at the radiology congress in late 2025. The competition between vendors on doses, speeds, and AI is driving the purchase decision toward an earlier replacement cycle. Investments in mobile and portable imaging technologies are facilitated in the region by federal and state investments for emergency preparedness.

Get Customized Report as Per Your Business Requirement - Enquiry Now
Europe Computed Tomography Market
Europe held the third-largest share of the market in 2025, with Germany leading country demand through its large hospital sector and dense scanner base. The United Kingdom, France, and Italy also invest in imaging capacity to shorten diagnostic waiting times, often through national programs and community diagnostic centers. Regional buyers value dose efficiency, interoperability, and strong service coverage, and they pay close attention to total cost of ownership when selecting systems under public procurement rules. Cross-border patient flows also support steady demand.
Regional manufacturing strength supports the market. Siemens Healthineers is headquartered in Germany, and Philips in the Netherlands, so European hospitals have close access to engineering support and clinical research partners. Radiation protection rules require dose tracking and justification of exposures, which drives demand for dose management software. Environmental and energy efficiency goals are also influencing procurement, and vendors increasingly promote scanners that use less power in standby and during examinations. Medical physicists play an influential role in equipment selection and protocol design.
Asia Pacific Computed Tomography Market
Asia Pacific is the fastest growing region, with a projected CAGR of 8.17% from 2026 to 2035. China holds the largest national share, supported by hospital expansion, government equipment renewal programs, and strong domestic manufacturers. Japan has a dense installed base and a large elderly population, while India is growing rapidly through private diagnostic chains and public screening initiatives. South Korea and Australia add demand through advanced hospitals. Rising incomes and insurance coverage widen the patient base for scans. Aging populations add demand.
Competition from regional manufacturers is intense and is lowering prices in mid-range systems. Global vendors respond with local production, financing, and service networks. Partnerships with leading cancer institutes support technology introduction in the region. For instance, new spectral systems are being installed at major oncology centers in India, which builds clinical experience that other hospitals follow. Government programs for early cancer detection and tuberculosis screening further raise the number of imaging examinations performed each year. Domestic vendors continue to gain share in provincial hospitals.
Latin America Computed Tomography Market
Latin America accounted for 4.96% of the market in 2025, with Brazil representing the leading national market. Large private hospital groups in Sao Paulo and other major cities invest in advanced scanners, while public hospitals expand capacity gradually under national health programs. Mexico, Argentina, Chile, and Colombia are also adding imaging equipment, often through public tenders and financing programs. Currency swings can affect equipment prices, so buyers favor leasing, refurbished systems, and manufacturer financing when budgets are constrained. Supplier competition is increasing.
Service availability is an important buying criterion because downtime is costly in regions with fewer qualified engineers. Global manufacturers maintain local offices and distributors, while some regional suppliers focus on refurbished equipment. Teleradiology helps hospitals in smaller cities share specialist expertise and justify scanner purchases. Cancer and cardiovascular disease are leading causes of death, and public campaigns for early detection are expected to raise demand for imaging examinations across the region over the forecast period. Training of technologists is also a growing priority.
Middle East & Africa Computed Tomography Market
The Middle East and Africa represented the smallest share at 4.52% in 2025. Saudi Arabia leads the regional market, supported by national health transformation programs, new hospital construction, and investment in specialist cancer and cardiac centers. The United Arab Emirates and Qatar follow with early adoption of premium systems in flagship hospitals and medical cities. Gulf governments tend to buy complete imaging packages from established suppliers, which favors vendors that offer training, service, and long-term maintenance agreements. Medical tourism further supports demand.
South Africa provides most of the demand in Africa, where private hospital groups invest in modern scanners. Elsewhere on the continent, scanner density remains very low, and access to computed tomography depends on a few urban hospitals. Donor programs, public-private partnerships, and leasing arrangements are important routes to market. Reliable power, trained technologists, and service support are limiting factors, so simple, rugged systems with strong remote support are better suited to many settings in the region. Training programs remain a priority.
Competitive Landscape
The Computed Tomography Market shows a consolidated structure. A small group of global imaging manufacturers account for most of the equipment sold, supported by large installed bases, research budgets, service networks, and broad portfolios that span other imaging modalities. Regional manufacturers, particularly from China, Japan, and South Korea, compete in mid-range and cost-sensitive segments, while specialist companies focus on cone beam, mobile, and dental scanners. Buyers weigh image quality, dose, uptime, software, and total cost over the equipment life.
Vendors follow four main strategic lines. Product launches introduce photon-counting detectors, artificial intelligence reconstruction, and faster workflows, regulatory clearances open new clinical uses, partnerships connect scanner makers with software developers and cancer centers, and funding of start-ups supports mobile and portable concepts. Companies also invest in service and cloud offerings, since recurring revenue from software, upgrades, and support is becoming a larger part of each customer relationship over the life of the scanner.
Computed Tomography Market Industry Leaders
1. GE HealthCare: Global imaging leader with a broad CT portfolio, including its newly cleared photon-counting system and AI-based reconstruction.
2. Siemens Healthineers: Pioneer of clinical photon-counting CT through its Naeotom Alpha class and supplier of a wide range of conventional scanners.
3. Koninklijke Philips N.V.: Provider of spectral and AI-enabled CT systems with a focus on workflow, dose reduction, and cardiology and oncology care.
4. Canon Medical Systems Corporation: Japanese manufacturer known for wide-detector and area-detector CT scanners and deep learning reconstruction.
5. United Imaging Healthcare: Chinese imaging company with a growing global presence in CT, including ultra-high-end and compact systems.
Companies Covered in this Report
- GE HealthCare
- Siemens Healthineers
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- United Imaging Healthcare
- FUJIFILM Holdings Corporation
- Neusoft Medical Systems Co., Ltd.
- NeuroLogica Corporation (Samsung Electronics)
- Shimadzu Corporation
- Planmeca Oy
- Koning Corporation
- Shenzhen Anke High-Tech Co., Ltd.
- Micro-X Limited
- HeartFlow, Inc.
Recent Industry Developments
- January 2025: Philips launched its AI-enabled CT 5300 scanner at the Asian Oceanian Congress of Radiology.
- February 2025: Micro-X received a USD 16.40 million grant from the Advanced Research Projects Agency for Health to develop a mobile, lightweight whole-body CT scanner.
- March 2025: Siemens Healthineers received FDA clearance for the Naeotom Alpha class of photon-counting CT scanners, including the Alpha.Pro, Alpha.Prime, and Alpha.Peak.
- July 2025: HeartFlow filed for a USD 100.00 million initial public offering to fund artificial intelligence integration in CT-based cardiovascular diagnostics.
- March 2026: GE HealthCare received FDA clearance for Photonova Spectra, its first photon-counting CT system with a silicon-based detector.
- March 2026: RAYDIAX secured about USD 8.20 million in venture capital and European Commission funding to advance its TACT CT system.
Scope and Research Methodology
This study defines the Computed Tomography Market as the CT scanners, including conventional, cone beam, and photon-counting systems, together with the embedded software used to acquire and reconstruct images for diagnosis, treatment planning, and procedure guidance. The base year is 2025, the forecast period runs from 2026 to 2035, and all values are expressed in USD. The market is segmented by product type, technology, application, end user, and region, and each segment is reported with its 2025 share and its forecast growth rate. Regional coverage spans North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with country-level detail for the leading national markets in each region.
The research program combines secondary and primary work. Secondary research draws on company annual reports, investor presentations, regulatory filings, device clearance databases, government health statistics, trade association data, product documentation, and peer-reviewed and industry publications. Primary research consists of structured interviews and surveys with executives, product and business heads, radiologists, imaging technologists, procurement managers, and hospital biomedical leaders across the value chain. These conversations validate assumptions on installed base, replacement cycles, pricing, and service revenue. Interview findings are compared across respondent groups so that vendor views are tested against buyer experience, and conflicting answers are resolved through follow-up discussions before they are accepted.
Market engineering follows a bottom-up build from vendor revenue, unit shipments, and installed base data, which is then cross-checked top-down against hospital capital spending, imaging procedure volumes, and sector indicators. Triangulation across these routes narrows differences before figures are finalized. Forecasts take into account disease burden, regulation, technology cost curves, reimbursement, and macroeconomic factors in each region. Every estimate passes a structured analyst quality review for consistency across segments and regions before it is released in the report. Estimates are refreshed as new regulatory decisions, company disclosures, and procurement data become available during the research cycle.
Computed Tomography Market Report Scope:
| Report Attributes | Details |
|---|---|
| Market Size in 2025 | USD 8.02 Billion |
| Market Size by 2035 | USD 14.61 Billion |
| CAGR | CAGR of 6.18% From 2026 to 2035 |
| Base Year | 2025 |
| Forecast Period | 2026-2035 |
| Historical Data | 2022-2024 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Conventional CT Scanners, Cone Beam CT Scanners, and Other Product Types) • By Technology (Iterative Reconstruction CT, Photon-Counting CT, Dual-Energy CT, and Other Technologies) • By Application (Oncology, Neurology, Cardiovascular, Musculoskeletal, and Other Applications) • By End User (Hospitals and Medical Centers, Diagnostic Imaging Centers, and Other End Users) |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
| Company Profiles | GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, United Imaging Healthcare, FUJIFILM Holdings Corporation, Neusoft Medical Systems Co., Ltd., NeuroLogica Corporation (Samsung Electronics), Shimadzu Corporation, Planmeca Oy, Koning Corporation, Shenzhen Anke High-Tech Co., Ltd., Micro-X Limited, HeartFlow, Inc. |
Frequently Asked Questions
The market was valued at USD 8.02 Billion in 2025 and is expected to reach USD 8.52 Billion in 2026 and USD 14.61 Billion by 2035.
The market is projected to grow at a CAGR of 6.18% from 2026 to 2035.
North America leads with a 35.40% share in 2025, supported by a large installed base and high procedure volumes.
Asia Pacific is expected to grow fastest, at a CAGR of 8.17% from 2026 to 2035.
GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, and United Imaging Healthcare are among the major players.